{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:50:08Z","timestamp":1793137808407,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001478.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T00:00:00Z","timestamp":1410912000000}}],"reference-count":153,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001478.pub6","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T08:11:10Z","timestamp":1410941470000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Acellular vaccines for preventing whooping cough in children"],"prefix":"10.1002","volume":"2014","author":[{"given":"Linjie","family":"Zhang","sequence":"first","affiliation":[{"name":"Federal University of Rio Grande; Faculty of Medicine; Rua Visconde Paranagu\u00e1 102 Centro Rio Grande RS Brazil 96201-900"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvio OM","family":"Prietsch","sequence":"additional","affiliation":[{"name":"Federal University of Rio Grande; Faculty of Medicine; Rua Visconde Paranagu\u00e1 102 Centro Rio Grande RS Brazil 96201-900"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Axelsson","sequence":"additional","affiliation":[{"name":"\u00d6stersund County Hospital; \u00d6stersund Sweden"},{"name":"Mid Sweden University; Department of Health Sciences; \u00d6stersund Sweden SE-831 25"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Halperin","sequence":"additional","affiliation":[{"name":"Halifax Dalhousie University, IWK Health Centre; Canadian Center for Vaccinology; 5850\/5980 University Avenue Halifax NS Canada B3K 6R8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/02724936.1996.11747802","article-title":"Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana","volume":"16","author":"Afari","year":"1996","journal-title":"Annals of Tropical Paediatrics"},{"issue":"8592","key":"10.1002\/14651858.CD001478.pub6-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(88)91778-3","article-title":"Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events","volume":"1","author":"Ad Hoc Group for the Study of Pertussis Vaccines","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archpedi.1991.02160110077024","article-title":"Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions","volume":"145","author":"Blackwelder","year":"1991","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0004|cit4","first-page":"1994","article-title":"Protective effect of 2 acellular pertussis vaccines in a double-blind placebo controlled clinical trial","volume":"85","author":"Kallings","year":"1988","journal-title":"Lakartidningen"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0005|cit5","first-page":"143","article-title":"Invasive bacterial infections during an efficacy trial of acellular pertussis vaccines - implications for future surveillance in pertussis vaccine programmes","volume":"13","author":"Olin","year":"1988","journal-title":"Tokai Journal of Experimental and Clinical Medicine"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0006|cit6","unstructured":"Olin P Storsaeter J Linder T Winter C S\u00f6nstenby C A clinical trial of acellular pertussis vaccines in Sweden Technical Report 1988 1988215677"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0264-410X(90)90246-I","article-title":"Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial","volume":"8","author":"Storsaeter","year":"1990","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub6-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00006454-198809000-00008","article-title":"Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden","volume":"7","author":"Storsaeter","year":"1988","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0009|cit9","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0010|cit10","first-page":"99","article-title":"Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0011|cit11","unstructured":"Olin P Gustafsson L Rasmussen H Hallander H Heijbel H Gottfarb P Efficacy trial of acellular pertussis vaccines. Technical report trial II with preplanned analysis of efficacy, immunogenicity and safety Swedish Institute for Infectious Disease Control 1997"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub6-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/157.4.731","article-title":"Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants","volume":"157","author":"Anderson","year":"1988","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub6-BIB0014|cit14","first-page":"556","article-title":"Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children","volume":"146","author":"Bernstein","year":"1992","journal-title":"American Journal of Diseases of Children"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub6-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1542\/peds.93.4.656","article-title":"Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants","volume":"93","author":"Bernstein","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00006454-199701000-00012","article-title":"Safety and immunogenicity of Chiron\/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers","volume":"16","author":"Black","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1542\/peds.82.3.293","article-title":"Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial","volume":"82","author":"Blennow","year":"1988","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0018|cit18","first-page":"185","article-title":"Preliminary data from a clinical trial (phase 2) of an acellular pertussis vaccine, J-NIH-6","volume":"65","author":"Blennow","year":"1986","journal-title":"Developments in Biological Standardization"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01962341","article-title":"Protective effect of acellular pertussis vaccines","volume":"7","author":"Blennow","year":"1988","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD001478.pub6-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(05)82442-4","article-title":"Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody","volume":"117","author":"Blumberg","year":"1990","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0021|cit21","first-page":"51","article-title":"Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines","volume":"73","author":"Cherry","year":"1991","journal-title":"Developments in Biological Standardization"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3476(05)80727-9","article-title":"Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group","volume":"119","author":"Blumberg","year":"1991","journal-title":"Journal of Pediatrics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001478.pub6-BIB0024|cit23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/infdis\/174.Supplement_3.S270","article-title":"The multicenter acellular pertussis trial: an overview","volume":"174","author":"Decker","year":"1996","journal-title":"Journal of Infectious Diseases"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD001478.pub6-BIB0023|cit24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"issue":"3 pt 2","key":"10.1002\/14651858.CD001478.pub6-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1542\/peds.96.3.592","article-title":"Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations","volume":"96","author":"Deloria","year":"1995","journal-title":"Pediatrics"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD001478.pub6-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub6-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archpedi.1986.02140230037024","article-title":"Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components","volume":"140","author":"Edwards","year":"1986","journal-title":"American Journal of Diseases of Children"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub6-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archpedi.1986.02140230037024","article-title":"Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components","volume":"140","author":"Edwards","year":"1986","journal-title":"American Journal of Diseases of Children"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub6-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub6-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub6-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/166.6.1436","article-title":"Controlled study of a new five-component acellular pertussis vaccine in adults and young children","volume":"166","author":"Englund","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-3476(05)80328-2","article-title":"Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15- to 24-month-old children","volume":"121","author":"Feldman","year":"1992","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"269-75, 284","DOI":"10.1097\/00007611-199303000-00002","article-title":"Primary immunization series for infants: comparison of two-component acellular and standard whole-cell pertussis vaccines combined with diphtheria-tetanus toxoids","volume":"86","author":"Feldman","year":"1993","journal-title":"Southern Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD001478.pub6-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00006454-199207000-00005","article-title":"Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17- to 24-month-old children","volume":"11","author":"Glode","year":"1992","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0038|cit38","first-page":"77","article-title":"Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials","volume":"89","author":"Ciofi degli Atti","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0040|cit39","first-page":"55","article-title":"Italian trial on acellular pertussis vaccines","volume":"89","author":"Greco","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0039|cit40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis","volume":"334","author":"Greco","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0041|cit41","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0042|cit42","first-page":"105","article-title":"Common side effects in the Italian and Stockholm I trials","volume":"89","author":"Tozzi","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0043|cit43","first-page":"77","article-title":"Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials","volume":"89","author":"Ciofi degli Atti","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0044|cit44","unstructured":"Gustaffson L Hallander H Olin P Reizenstein E Storsaeter J Efficacy trial of acellular pertussis vaccines. Technical report Trial I with results of preplanned analysis of safety, efficacy and immunogenicity Swedish Institute for Infectious Disease Control 1995"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0046|cit46","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0047|cit47","first-page":"52","article-title":"Efficacy trial of acellular pertussis vaccines; trial I","volume":"89","author":"Olin","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0048|cit48","first-page":"105","article-title":"Common side effects in the Italian and Stockholm I trials","volume":"89","author":"Tozzi","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub6-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archpedi.1994.02170110106025","article-title":"Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities","volume":"148","author":"Halperin","year":"1994","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub6-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archpedi.1994.02170110106025","article-title":"Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities","volume":"148","author":"Halperin","year":"1994","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub6-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199509000-00012","article-title":"Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole-cell or acellular pertussis vaccine at two, four and six months of age","volume":"14","author":"Halperin","year":"1995","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub6-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0264-410X(95)00250-5","article-title":"Adverse reactions and antibody response to four doses of acellular or whole-cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life","volume":"14","author":"Halperin","year":"1996","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub6-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00006454-199909000-00006","article-title":"Comparison of a fifth dose of a five-component acellular or a whole-cell pertussis vaccine in children four to six years of age","volume":"18","author":"Halperin","year":"1999","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"19-20","key":"10.1002\/14651858.CD001478.pub6-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/S0264-410X(03)00173-7","article-title":"Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine","volume":"21","author":"Halperin","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0264-410X(94)90014-0","article-title":"Comparative study of Lederle\/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany","volume":"12","author":"Heininger","year":"1994","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01955054","article-title":"Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children","volume":"152","author":"Kanra","year":"1993","journal-title":"European Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01955054","article-title":"Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children","volume":"152","author":"Kanra","year":"1993","journal-title":"European Journal of Pediatrics"},{"issue":"27-30","key":"10.1002\/14651858.CD001478.pub6-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1016\/S0264-410X(03)00496-1","article-title":"Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine","volume":"21","author":"Kosuwon","year":"2003","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub6-BIB0059|cit59","first-page":"872","article-title":"A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children","volume":"140","author":"Lewis","year":"1986","journal-title":"American Journal of Diseases of Children"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0060|cit60","first-page":"290","article-title":"Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children","volume":"147","author":"Marcinak","year":"1993","journal-title":"American Journal of Diseases of Children"},{"issue":"8733","key":"10.1002\/14651858.CD001478.pub6-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0140-6736(91)90735-8","article-title":"Phase II trial of whole-cell pertussis vaccine versus an acellular vaccine containing agglutinogens","volume":"337","author":"Miller","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0062|cit62","first-page":"51","article-title":"Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines","volume":"73","author":"Cherry","year":"1991","journal-title":"Developments in Biological Standardization"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD001478.pub6-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1203\/00006450-199004000-00007","article-title":"Metabolic and hematologic effects and immune complex formation related to pertussis immunization","volume":"27","author":"Mink","year":"1990","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archpedi.1990.02150250047029","article-title":"Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children","volume":"144","author":"Morgan","year":"1990","journal-title":"American Journal of Diseases of Children"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD001478.pub6-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.89.5.882","article-title":"Acellular pertussis vaccination of 2-month-old infants in the United States","volume":"89","author":"Pichichero","year":"1992","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0066|cit66","first-page":"295","article-title":"Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants","volume":"147","author":"Pichichero","year":"1993","journal-title":"American Journal of Diseases of Children"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00006454-199403000-00005","article-title":"Comparison of a three-component acellular pertussis vaccine with whole-cell pertussis vaccine in two-month-old children","volume":"13","author":"Pichichero","year":"1994","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00365549609049068","article-title":"Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole-cell pertussis vaccine","volume":"28","author":"Pichichero","year":"1996","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub6-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.100.5.772","article-title":"A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children","volume":"100","author":"Pichichero","year":"1997","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1542\/peds.105.1.e11","article-title":"Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children","volume":"105","author":"Pichichero","year":"2000","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3476(05)83181-6","article-title":"Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine","volume":"124","author":"Podda","year":"1994","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0072|cit72","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0073|cit73","first-page":"113","article-title":"Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine","volume":"89","author":"Schmitt-Grohe","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0075|cit74","first-page":"58","article-title":"A comparative efficacy trial in Germany in which infants received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine","volume":"89","author":"Stehr","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0074|cit75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.101.1.1","article-title":"A comparative efficacy trial in Germany in infants who received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine","volume":"101","author":"Stehr","year":"1998","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0076|cit76","first-page":"83","article-title":"Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine","volume":"89","author":"Uberall","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub6-BIB0077|cit77","first-page":"854","article-title":"Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines","volume":"147","author":"Rothstein","year":"1993","journal-title":"American Journal of Diseases of Children"},{"issue":"12","key":"10.1002\/14651858.CD001478.pub6-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/BF01690510","article-title":"Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants","volume":"15","author":"Simondon","year":"1996","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0079|cit79","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0080|cit80","first-page":"91","article-title":"The Senegal pertussis trial: safety and surveillance of adverse reactions","volume":"89","author":"Preziosi","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0082|cit81","first-page":"63","article-title":"Senegal pertussis trial","volume":"89","author":"Simondon","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"15","key":"10.1002\/14651858.CD001478.pub6-BIB0081|cit82","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0264-410X(97)00100-X","article-title":"A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal","volume":"15","author":"Simondon","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0083|cit83","first-page":"155","article-title":"An observation on immunization reaction and serological effect of adsorbed purified pertussis vaccine","volume":"14","author":"Tian","year":"1993","journal-title":"Chung Hua Liu Hsing Ping Hsueh Tsa Chih"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0084|cit84","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies","volume":"89","author":"Heijbel","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0085|cit85","first-page":"109","article-title":"Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial","volume":"89","author":"Taranger","year":"1997","journal-title":"Developments in Biological Standardization"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0087|cit86","first-page":"49","article-title":"The Gothenburg pertussis vaccine study","volume":"89","author":"Trollfors","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"16","key":"10.1002\/14651858.CD001478.pub6-BIB0086|cit87","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0264-410X(94)90196-1","article-title":"Study of pertussis vaccines in infants: comparison of response to acellular pertussis DTP vaccines containing 25 micrograms of FHA and either 25 or 8 micrograms of PT with response to whole-cell pertussis DTP vaccine","volume":"12","author":"Vanura","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub6-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpedi.1994.02170050061011","article-title":"Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates","volume":"148","author":"Annunziato","year":"1994","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00006454-199302000-00005","article-title":"Comparison of acellular pertussis vaccine with whole-cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age","volume":"12","author":"Bernstein","year":"1993","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"17","key":"10.1002\/14651858.CD001478.pub6-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/0264-410X(95)00137-P","article-title":"Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States","volume":"13","author":"Bernstein","year":"1995","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/02724936.1994.11747699","article-title":"A randomized controlled trial of two acellular pertussis-diphtheria-tetanus vaccine in primary immunization in Ghana: antibody responses and adverse reactions","volume":"14","author":"Hori","year":"1994","journal-title":"Annals of Tropical Paediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02724936.1995.11747762","article-title":"Pertussis immunization with acellular vaccines in Ghanaian children","volume":"15","author":"Hori","year":"1995","journal-title":"Annals of Tropical Paediatrics"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0094|cit94","first-page":"275","article-title":"Two trials of an acellular DTP vaccine in comparison with a whole-cell DTP vaccine in infants: evaluation of two PT doses and two vaccination schedules","volume":"73","author":"Just","year":"1991","journal-title":"Developments in Biological Standardization"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0264-410X(96)00112-0","article-title":"Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance","volume":"15","author":"Miller","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1542\/peds.71.2.200","article-title":"Evaluation of the pertussis components of diphtheria-tetanus-pertussis vaccine","volume":"71","author":"Murphy","year":"1983","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub6-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006454-198704000-00004","article-title":"Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis versus a whole-cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children","volume":"6","author":"Pichichero","year":"1987","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub6-BIB0098|cit98","first-page":"863","article-title":"Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants","volume":"34","author":"Shek","year":"2003","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00431-007-0548-2","article-title":"What is new in pertussis?","volume":"167","author":"Bamberger","year":"2008","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(05)62352-5","article-title":"Does blinding of readers affect the results of meta-analyses?","volume":"350","author":"Berlin","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.inf.0000247055.81541.04","article-title":"The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada","volume":"26","author":"Bettinger","year":"2007","journal-title":"Pediatric Infectious Disease"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1542\/peds.2004-2759","article-title":"Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001","volume":"116","author":"Bisgard","year":"2005","journal-title":"Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub6-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archpedi.1991.02160110077024","article-title":"Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions","volume":"145","author":"Blackwelder","year":"1991","journal-title":"American Journal of Diseases of Children"},{"issue":"42","key":"10.1002\/14651858.CD001478.pub6-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1016\/j.vaccine.2009.07.092","article-title":"Control of pertussis - lessons learnt from a 10-year surveillance programme in Sweden","volume":"27","author":"Carlsson","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/14651858.CD001478.pub6-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2165\/00003495-200565100-00005","article-title":"Acellular pertussis vaccine safety and efficacy in children, adolescents and adults","volume":"65","author":"Casey","year":"2005","journal-title":"Drug"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0106|cit106","unstructured":"Centers for Disease Control Recommendations and Guidelines: 2009 Child and Adolescent Immunization Schedules www.cdc.gov\/vaccines\/recs\/schedules\/child-schedule.htm 2009"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0107|cit107","first-page":"4","article-title":"Local health department costs associated with response to a school-based pertussis outbreak - Omaha, Nebraska, September-November 2008","volume":"60","author":"Centers for Disease Control","year":"2011","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001478.pub6-BIB0108|cit108","first-page":"8259","article-title":"Historical review of pertussis and the classical vaccine","volume":"174","author":"Cherry","year":"1996","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1901-6","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD001478.pub6-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp1209051","article-title":"Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease","volume":"367","author":"Cherry","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","article-title":"Language bias in randomised controlled trials published in English and German","volume":"350","author":"Egger","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub6-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"e10178","DOI":"10.1371\/journal.pone.0010178","article-title":"T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis","volume":"5","author":"Feunou","year":"2010","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0113|cit113","first-page":"123","article-title":"Implications of different study designs for the evaluation of acellular pertussis vaccines","volume":"89","author":"Fine","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"12","key":"10.1002\/14651858.CD001478.pub6-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1086\/426020","article-title":"New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative","volume":"39","author":"Forsyth","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub6-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1503\/cmaj.050379","article-title":"Changing epidemiology and emerging risk groups for pertussis","volume":"174","author":"Galanis","year":"2006","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0116|cit116","first-page":"379","article-title":"Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease?","volume":"89","author":"Granoff","year":"1997","journal-title":"Developments in Biological Standardization"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1542\/peds.2005-2746","article-title":"Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age","volume":"118","author":"Gustafsson","year":"2006","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"b1772","DOI":"10.1136\/bmj.b1772","article-title":"Practice: Easily missed? Whooping cough","volume":"338","author":"Harnden","year":"2009","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub6-BIB0119|cit119","first-page":"844","article-title":"A clinical trial of a monocomponent pertussis toxoid vaccine","volume":"141","author":"Hedenskog","year":"1987","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0120|cit120","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"issue":"27-8","key":"10.1002\/14651858.CD001478.pub6-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.vaccine.2004.03.046","article-title":"Impact of routine vaccination with a pertussis toxoid vaccine in Denmark","volume":"22","author":"Hviid","year":"2004","journal-title":"Vaccine"},{"issue":"13","key":"10.1002\/14651858.CD001478.pub6-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.vaccine.2005.12.009","article-title":"Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review","volume":"24","author":"Jacquet","year":"2006","journal-title":"Vaccine"},{"issue":"17-18","key":"10.1002\/14651858.CD001478.pub6-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0264-410X(02)00770-3","article-title":"Systematic review of the effects of pertussis vaccines in children","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100960050435","article-title":"Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity","volume":"19","author":"Kerr","year":"2000","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1442-200x.2004.01970.x","article-title":"Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization","volume":"46","author":"Kuno-Sakai","year":"2004","journal-title":"Pediatrics International"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0126|cit126","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"11","key":"10.1002\/14651858.CD001478.pub6-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/00006454-199711000-00007","article-title":"Efficacy of a two-component acellular pertussis vaccine in infants","volume":"16","author":"Liese","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD001478.pub6-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMc1212006","article-title":"Priming with whole-cell versus acellular pertussis vaccine","volume":"368","author":"Liko","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD001478.pub6-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bjs.6302","article-title":"Assessment of publication bias for the surgeon scientist","volume":"95","author":"Mahid","year":"2008","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infection and Immunity"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/biol.1999.0183","article-title":"The immunology of Bordetella pertussis infection","volume":"27","author":"Mills","year":"1999","journal-title":"Biologicals"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0132|cit132","volume-title":"Meta-analysis, Decision Analysis and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine","author":"Petitti","year":"1989"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD001478.pub6-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.inf.0000166157.21561.78","article-title":"Acellular pertussis vaccines for adolescents","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"7","key":"10.1002\/14651858.CD001478.pub6-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0009922806289593","article-title":"Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP\/DTwP schedules","volume":"45","author":"Pichichero","year":"2006","journal-title":"Clinical Pediatrics"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"401-9","DOI":"10.1086\/589862","article-title":"Correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0136|cit136","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1016\/j.vaccine.2008.09.042","article-title":"Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: a systematic review","volume":"26","author":"Rodr\u00edguez-Cobo","year":"2008","journal-title":"Vaccine"},{"issue":"8369","key":"10.1002\/14651858.CD001478.pub6-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a pertussis component vaccine in Japan","volume":"1","author":"Sato","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001478.pub6-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1996.03530250041024","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD001478.pub6-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.2012.6364","article-title":"Number and order of whole cell pertussis vaccines in infancy and disease protection","volume":"308","author":"Sheridan","year":"2012","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0012-3692(15)37335-9","article-title":"Whooping cough","volume":"130","author":"Singh","year":"2006","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/527402","article-title":"Vaccines for the unvaccinated: protecting the herd","volume":"197","author":"Stephens","year":"2008","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"1907-16","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00006454-199702000-00003","article-title":"Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants","volume":"16","author":"Taranger","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315318","article-title":"Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis","volume":"181","author":"Taranger","year":"2000","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0264-410X(98)00072-3","article-title":"Antibody and cell-mediated immune responses to booster immunisation with a new acellular pertussis vaccine in school children","volume":"16","author":"Tran Minh","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/14760584.4.2.173","article-title":"Acellular pertussis vaccines in Japan: past, present and future","volume":"4","author":"Watanabe","year":"2005","journal-title":"Expert Review of Vaccines"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0148|cit148","unstructured":"World Health Organization WHO meeting on case definitions of pertussis MIN\/EPI\/PERT\/91 1991 4 5"},{"key":"10.1002\/14651858.CD001478.pub6-BIB0149|cit149","first-page":"385-400","article-title":"Pertussis vaccines: WHO position paper","volume":"No. 40, 85","author":"World Health Organization","year":"2010","journal-title":"Weekly Epidemiological Record, WHO"},{"issue":"2","key":"10.1002\/14651858.CD001478.pub6-BIB0150|cit150","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001478.pub2","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Tinnion","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub6-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001478.pub2","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Tinnion","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001478.pub6-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001478.pub4","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Zhang","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD001478.pub6-BIB0153|cit153","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001478.pub5","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Zhang","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001478.pub6\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:53:04Z","timestamp":1695016384000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001478.pub6"}},"subtitle":[],"editor":[{"name":"Cochrane Acute Respiratory Infections Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,17]]},"references-count":153,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001478.pub6","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,17]]}}}